Guggenheim Reiterates Buy Rating on Axsome Therapeutics (AXSM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: AXSM) | Delayed: 156.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.07 | 52 Week High | $15.74 | |||
| Open | $156.07 | 52 Week Low | $5.37 | |||
| Day High | $156.07 | P/E | N/A | |||
| Day Low | $156.07 | EPS | $0.00 | |||
| Volume | 403 | |||||
